Stockscreener 앱 받기
30.44
5.84%
1.68
시간 외 거래:
30.20
-0.24
-0.79%
전일 마감가:
$28.76
열려 있는:
$28.745
하루 거래량:
17,863
Relative Volume:
0.35
시가총액:
$285.45M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.55%
1개월 성능:
+15.57%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$28.75
$30.65
1주일 범위
$28.20
$30.69
52주 변동 폭
$15.80
$34.31
Tvardi Therapeutics Inc Stock (TVRD) Company Profile
명칭
Tvardi Therapeutics Inc
전화
(713) 489-8654
주소
3 SUGAR CREEK CTR. BLVD., SUGAR LAND
TVRD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TVRD
Tvardi Therapeutics Inc
|
30.44 | 277.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tvardi Therapeutics Inc Stock (TVRD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-14 | 개시 | Raymond James | Outperform |
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 개시 | Piper Sandler | Overweight |
| 2025-05-21 | 개시 | Oppenheimer | Outperform |
| 2025-05-15 | 개시 | BTIG Research | Buy |
| 2024-06-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-06-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-06-13 | 다운그레이드 | Needham | Buy → Hold |
| 2024-06-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-03-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-03-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-11-01 | 재개 | Canaccord Genuity | Buy |
| 2021-08-03 | 개시 | JP Morgan | Neutral |
| 2020-04-21 | 재확인 | H.C. Wainwright | Buy |
| 2019-08-12 | 재확인 | H.C. Wainwright | Buy |
| 2019-05-29 | 재확인 | Laidlaw | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2019-01-15 | 개시 | BofA/Merrill | Neutral |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-09-13 | 개시 | Jefferies | Buy |
| 2018-08-08 | 재확인 | Stifel | Buy |
| 2018-06-28 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-12 | 재개 | H.C. Wainwright | Buy |
| 2018-02-12 | 업그레이드 | Janney | Neutral → Buy |
| 2018-01-19 | 개시 | Seaport Global Securities | Buy |
모두보기
Tvardi Therapeutics Inc 주식(TVRD)의 최신 뉴스
What are Tvardi Therapeutics Inc.’s technical support levelsEarnings Growth Summary & Risk Adjusted Buy/Sell Alerts - khodrobank.com
Visual trend scoring systems applied to Tvardi Therapeutics Inc.Quarterly Profit Review & Daily Oversold Bounce Ideas - Newser
What’s Tvardi Therapeutics Inc.’s historical returnShare Buyback & Consistent Return Investment Signals - khodrobank.com
Will breakout in Tvardi Therapeutics Inc. lead to full recoveryJuly 2025 Big Picture & High Return Stock Watch Alerts - Newser
Published on: 2025-09-03 09:20:00 - Newser
Is now a turning point for Tvardi Therapeutics Inc.Weekly Risk Report & Verified Entry Point Signals - Newser
Is Tvardi Therapeutics Inc. stock poised for growthMarket Performance Summary & Weekly High Potential Alerts - Newser
How to read the order book for Tvardi Therapeutics Inc.Buy Signal & Accurate Entry/Exit Alerts - Newser
What momentum shifts mean for Tvardi Therapeutics Inc.2025 Risk Factors & Expert Approved Trade Ideas - Newser
Can trapped investors hope for a rebound in Tvardi Therapeutics Inc.2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - Newser
Market Overview: Can Tvardi Therapeutics Inc. deliver consistent EPS growthPortfolio Return Summary & High Conviction Buy Zone Alerts - khodrobank.com
Is it too late to sell Tvardi Therapeutics Inc.Earnings Trend Report & Daily Profit Maximizing Tips - Newser
What’s the RSI of Tvardi Therapeutics Inc. stockQuarterly Earnings Summary & Consistent Profit Trading Strategies - khodrobank.com
Does Tvardi Therapeutics Inc. qualify in momentum factor screeningTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Short interest data insights for Tvardi Therapeutics Inc.Take Profit & Long-Term Capital Growth Strategies - Newser
What recovery options are there for Tvardi Therapeutics Inc.July 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
Identifying reversal signals in Tvardi Therapeutics Inc.Market Movement Recap & High Accuracy Buy Signal Tips - Newser
Real time social sentiment graph for Tvardi Therapeutics Inc.Quarterly Portfolio Summary & Stepwise Trade Signal Implementation - Newser
What are the analyst revisions for Tvardi Therapeutics Inc.Is QNST stock a good investment in YEAR2025 Dividend Review & AI Based Trade Execution Alerts - khodrobank.com
Tvardi Therapeutics Inc. Included in Top Momentum Scan getLinesFromResByArray error: size == 0 - thegnnews.com
Why Tvardi Therapeutics Inc. is moving todayJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser
Can Tvardi Therapeutics Inc. deliver consistent EPS growthMarket Performance Summary & Free Long-Term Investment Growth Plans - khodrobank.com
How to use Fibonacci retracement on Tvardi Therapeutics Inc.Weekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Applying Elliott Wave Theory to Tvardi Therapeutics Inc.Inflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Tvardi Therapeutics Inc. stock chart pattern explainedQuarterly Trade Review & High Conviction Buy Zone Alerts - Newser
Can Tvardi Therapeutics Inc. recover in the next quarter2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Is Tvardi Therapeutics Inc. reversing from oversold territory2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser
Tvardi Therapeutics (NASDAQ:TVRD) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tvardi Therapeutics Faces Legal and Financial Risks from Exclusive Forum Provision - MSN
Volatility clustering patterns for Tvardi Therapeutics Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
How to manage a losing position in Tvardi Therapeutics Inc.July 2025 Technicals & Low Risk Entry Point Guides - Newser
Tvardi Therapeutics Inc (TVRD) 재무 분석
Tvardi Therapeutics Inc (TVRD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Tvardi Therapeutics Inc 주식 (TVRD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. |
Feb 28 '25 |
Sale |
4.76 |
163 |
776 |
7,190 |
| Posner Christopher | PRESIDENT AND CEO |
Feb 04 '25 |
Sale |
4.72 |
372 |
1,756 |
13,692 |
| Posner Christopher | PRESIDENT AND CEO |
Nov 04 '24 |
Sale |
0.29 |
3,668 |
1,064 |
168,768 |
1.75%
1.11%
자본화:
|
볼륨(24시간):